Sekisui Chemical Co., Ltd.

Sekisui Chemical Co., Ltd.

14.40
EUR
+0.10
(+0.70%)
5.85BMarket Cap
Oct 30Next Earn
Sekisui Chemical Co., Ltd.
STU:SUI
(Stuttgart Stock Exchange)

Recent

price

14.40

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
JPY
1,744.44
1,852.29
2,002.66
2,160.95
2,198.98
2,226.92
2,209.13
2,334.97
2,450.6
2,457.6
2,337.72
2,598.03
2,855.73
2,958.42
3,103.68
3,182.05
- -
Revenue per Share
44.92
53.96
58.53
80.13
104.73
115.08
126.13
133.8
141.74
128.8
91.92
83.17
159.19
183.48
195.93
182.7
- -
Basic EPS, GAAP
77.05
73.44
75.58
128
54.62
53.34
141.81
68.6
40.79
77.08
29.21
135.54
34.79
108.72
116.98
-85.76
- -
Free Cash Flow per Basic Share
10.02
15.04
17.03
20.14
25.18
28.07
32.21
38.23
42.26
46.32
46.36
48.31
54.74
65.52
76.37
83.02
- -
Dividend per Share
652
683.38
811.35
897.71
1,034.32
1,072.29
1,148.78
1,246.48
1,308.08
1,333.89
1,485.89
1,519.19
1,642.67
1,880.29
1,933.56
2,108.44
- -
Book Value per Share
594.89
582.67
716.25
819.49
966.05
982.75
1,066.05
1,138.17
1,198.71
1,105.13
1,268.38
1,413.95
1,523.84
1,740.05
1,791.94
1,965.84
- -
Tangible Book Value per Share
525
521
516
514
506
492
482
474
466
459
452
446
435
425
418
411
407
Basic Weighted Avg Shares
915,492
965,090
1,032,431
1,110,851
1,112,748
1,096,317
1,065,776
1,107,429
1,142,713
1,129,254
1,056,560
1,157,945
1,242,521
1,256,538
1,297,754
1,309,281
- -
Sales/Revenue/Turnover
5.39
5.66
5.77
7.43
7.71
8.19
9.05
8.96
8.37
7.79
6.37
7.68
7.38
7.51
8.32
8.13
- -
Operating Margin (%)
37,260
38,524
38,127
37,333
33,551
36,891
36,961
38,432
41,637
45,256
49,345
48,704
52,406
52,672
53,756
58,124
- -
Depreciation Expense
23,574
28,116
30,174
41,190
52,995
56,653
60,850
63,459
66,093
59,181
41,544
37,067
69,263
77,930
81,925
75,174
- -
Net Income, GAAP
37.99
41.01
29.83
41.5
35.55
25.94
25.29
29.28
27.08
26.94
31.5
44.52
28.87
29.09
29.9
26.35
- -
Effective Tax Rate (%)
2.58
2.91
2.92
3.71
4.76
5.17
5.71
5.73
5.78
5.24
3.93
3.2
5.57
6.2
6.31
5.74
- -
Profit Margin (%)
78,384
76,305
104,425
106,295
132,738
119,569
176,020
160,151
158,857
157,671
223,293
279,701
293,672
340,967
363,102
333,114
- -
Working Capital
81,080
83,532
64,776
36,955
34,120
16,193
27,028
25,018
25,538
76,505
126,264
113,263
111,732
103,691
103,067
108,841
- -
LT Debt
350,045
363,298
433,226
473,553
535,291
544,154
570,548
612,756
632,744
634,217
694,391
702,752
732,524
820,924
835,365
881,123
- -
Total Equity
5.24
6.46
7.88
8.46
9.23
10.96
11.73
10.82
10.2
8.8
5.74
5.83
7.61
7.31
7.84
7.82
- -
Return on Invested Capital (%)
4.9
5.89
5.95
7.41
9.03
9.45
9.95
9.51
9.52
8.02
5.1
4.32
8.15
8.65
8.53
7.51
- -
Return on Capital (%)
6.9
8.12
7.83
9.4
10.88
10.89
11.34
11.15
11.06
9.73
6.51
5.53
10.04
10.41
10.24
9.07
- -
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
35,942
- -
LT Borrowings
- -
91,179
- -
LT Finance Leases
- -
17,662
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
407
404
404
Market Capitalization
1,063,173
1,073,742
1,049,956

Working Capital

JPY

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
721,698
- -
Cash, Cash Equivalents & STI
- -
97,192
- -
Accounts Receivable, Net
- -
213,491
- -
Inventories
- -
353,916
- -
Total Current Liabilities
- -
388,584
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
35,942
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5%
4.95%
5.48%
Free Cash Flow
41.15%
64.29%
-172.14%
Net Income, GAAP
6.11%
17.1%
-8.24%
Sales/Revenue/Turnover
1.89%
4.44%
0.89%
Total Cash Common Dividend
9.62%
10.39%
6.97%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
1,297,754
2026
- -
- -
- -
- -
1,309,281
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
195.93
2026
- -
- -
- -
- -
182.7
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
76.37
2026
- -
- -
- -
- -
83.02
2027
- -
- -
- -
- -
- -
Business
Sekisui Chemical Co., Ltd. manufactures and markets high-performance plastics, urban infrastructure and environmental products, housing solutions, and medical products worldwide. The High Performance Plastics segment provides LCD fine particles, photosensitive materials, semiconductor materials, optical films, and industrial tapes for electronics; interlayer films for laminated glass, polyolefin foams, resins and rubber molded products for vehicles, heat release materials, carbon fiber reinforced plastic composite mold materials, decorative plastic sheets, and polyvinyl alcohol resin for mobility; and blow containers, construction materials, adhesives, packaging tapes, plastic containers, functional tatami, and hygiene materials for industrial applications. The Urban Infrastructure & Environmental Products segment offers polyvinyl chloride and polyethylene pipes and fittings, plastic valves, reinforced plastic composite pipes, resin raw materials for heat-resistant pipes, chlorinated PVC resin compounds, rainwater storage systems, building materials including rain gutters and exterior materials, nursing care equipment, unit baths, synthetic lumber, vibration absorbing materials, non-flammable polyurethanes, fire-resistant materials, and infrastructure renovation services. The Housing segment develops and sells SEKISUI HEIM steel frame modular and wooden frame modular housing, building lots, housing renovation services via SEKISUI Fami S, real estate brokerage, apartment leasing and management, ready-built condominiums under HEIM SUITE, and residential interior/exterior decoration services; while the Medical segment supplies in-vitro diagnostics reagents and analyzers, vacuum blood collection tubes, active pharmaceutical ingredients, pharmaceutical intermediates, drug development solutions, and enzyme materials. Founded in 1947 and headquartered in Osaka, Japan, the company operates globally with facilities in regions including North America, Europe, Asia, and a growing presence in India. Recent developments include a JPY 90 billion investment announced in December 2024 for a 100 MW perovskite solar production line via Sekisui Solar Film, targeting commercial launch in fiscal 2027 with Japanese government subsidies; expansion of Indian automotive injection molding operations through SEKISUI DLJM MOLDING with a new Pune plant launching early 2026 to boost capacity 15% toward $130 million net sales by fiscal 2030; a master license agreement with LanzaTech in September 2024 for waste-to-ethanol technology commercialization; and acquisition of Creast in October 2024.

Company News

  • Sekisui Chemical Co., Ltd. (SKSUY) Q3 2025 Earnings Call Prepared Remarks Transcript

  • Sekisui Chemical (OTCMKTS:SKSUY) Shares Down 11.1% – Here’s Why

  • SEKISUI CHEMICAL Achieves Progress in Creating PFAS-Free Pipes for Ultrapure Process Applications in the Manufacturing of Advanced Semiconductors

  • SEKISUI CHEMICAL: New Injection Molding Plant for Interior/Exterior Parts of Automobiles in Pune

  • SEKISUI CHEMICAL: Victory in German Patent Infringement Lawsuit Concerning PVB Interlayer Films

  • Vinyl Chloride Patent Landscape Database 2010-2024 Featuring Leading VC Players - LG Chemical,, Zeon, Sekisui Chemical, Kaneka, and Adeka

  • SEKISUI CHEMICAL: Filing of Lawsuit Seeking Injunction and Damages for Patent Infringement in Relation to PVB Interlayer in Germany and Korea